Kala Pharmaceuticals Inc. buy BiotechBee
Start price
23.10.24
/
80%
€5.51
Target price
28.02.27
€6.50
Performance (%)
5.26%
End price
14.12.24
€5.80
Summary
This prediction ended on 14.12.24 with a price of €5.80. The BUY prediction by BiotechBee finished with a performance of 5.26%. BiotechBee has a follow-up prediction for Kala Pharmaceuticals Inc. where he still thinks Kala Pharmaceuticals Inc. is a Buy. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | -12.956% | -12.956% |
| iShares Core DAX® | -1.351% | 0.610% |
| iShares Nasdaq 100 | -1.453% | 3.019% |
| iShares Nikkei 225® | -0.021% | 1.195% |
| iShares S&P 500 | -1.326% | 2.830% |
According to BiotechBee what are the pros and cons of Kala Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kala Pharmaceuticals diskutieren
In the thread Trading Kala Pharmaceuticals
Current prediction by BiotechBee for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.11
21.07.25
21.07.25
€8.00
27.06.27
27.06.27
30.85%
05.08.25
05.08.25
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.24
08.09.24
08.09.24
€8.00
30.04.27
30.04.27
5.25%
23.10.24
23.10.24
Could be very worthwhile Investment >20% year